134 related articles for article (PubMed ID: 10366196)
1. Age-dependent increase in ischemic brain injury in wild-type mice and in mice lacking the inducible nitric oxide synthase gene.
Nagayama M; Aber T; Nagayama T; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 1999 Jun; 19(6):661-6. PubMed ID: 10366196
[TBL] [Abstract][Full Text] [Related]
2. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
[TBL] [Abstract][Full Text] [Related]
3. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning.
Cho S; Park EM; Zhou P; Frys K; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 2005 Apr; 25(4):493-501. PubMed ID: 15689953
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury.
Park EM; Cho S; Frys KA; Glickstein SB; Zhou P; Anrather J; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 2006 Mar; 26(3):392-401. PubMed ID: 16049426
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase does not mediate brain damage after transient focal cerebral ischemia in mice.
Prüss H; Prass K; Ghaeni L; Milosevic M; Muselmann C; Freyer D; Royl G; Reuter U; Baeva N; Dirnagl U; Meisel A; Priller J
J Cereb Blood Flow Metab; 2008 Mar; 28(3):526-39. PubMed ID: 17851454
[TBL] [Abstract][Full Text] [Related]
6. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
7. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats.
Nagayama M; Zhang F; Iadecola C
J Cereb Blood Flow Metab; 1998 Oct; 18(10):1107-13. PubMed ID: 9778187
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
9. Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression.
Liang M; Ekblad E; Lydrup ML; Nilsson BO
Cell Tissue Res; 2003 Jul; 313(1):63-70. PubMed ID: 12827494
[TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.
Iadecola C; Sugimoto K; Niwa K; Kazama K; Ross ME
J Cereb Blood Flow Metab; 2001 Dec; 21(12):1436-41. PubMed ID: 11740205
[TBL] [Abstract][Full Text] [Related]
11. Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase.
Zhao X; Haensel C; Araki E; Ross ME; Iadecola C
Brain Res; 2000 Jul; 872(1-2):215-8. PubMed ID: 10924696
[TBL] [Abstract][Full Text] [Related]
12. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
13. Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase.
Lemack GE; Zimmern PE; Vazquez D; Connell JD; Lin VK
J Urol; 2000 Jun; 163(6):1981-7. PubMed ID: 10799243
[TBL] [Abstract][Full Text] [Related]
14. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury.
Parmentier-Batteur S; Bohme GA; Lerouet D; Zhou-Ding L; Beray V; Margaill I; Plotkine M
J Cereb Blood Flow Metab; 2001 Jan; 21(1):15-21. PubMed ID: 11149663
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypertonic saline resuscitation on CD4+CD25+ regulatory T cells and gammadelta T cells after hemorrhagic shock and resuscitation in relation to apoptosis and iNOS.
Murao Y; Isayama K; Saito F; Hirakawa A; Nakatani T
J Trauma; 2009 Nov; 67(5):975-82. PubMed ID: 19901657
[TBL] [Abstract][Full Text] [Related]
17. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.
Iadecola C; Zhang F; Casey R; Nagayama M; Ross ME
J Neurosci; 1997 Dec; 17(23):9157-64. PubMed ID: 9364062
[TBL] [Abstract][Full Text] [Related]
18. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.
Kilic E; Kilic U; Reiter RJ; Bassetti CL; Hermann DM
J Pineal Res; 2005 Sep; 39(2):151-5. PubMed ID: 16098092
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.
Caso JR; Pradillo JM; Hurtado O; Lorenzo P; Moro MA; Lizasoain I
Circulation; 2007 Mar; 115(12):1599-608. PubMed ID: 17372179
[TBL] [Abstract][Full Text] [Related]
20. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
